Benitec Biopharma Ltd ADR
Price & Volume
Stats
See moreOpen | $10.25 |
Previous Close | $10.53 |
Day Range | $9.80-$10.26 |
52W Range | $4.26-$13.29 |
Market Cap | $215.3M |
Shares Short | 127,995 |
Financials
See moreRevenue (12 Mos) | $7,000 |
Revenue Growth (YoY) | 12.5% |
Gross Profit (12 Mos) | $75,000 |
Diluted EPS | -$5.51 |
News
See moreYahoo Finance • 11 days ago
Benitec Biopharma Releases Second Quarter 2025 Financial Results and Provides Operational Update
Yahoo Finance • last year
Benitec Biopharma Announces First Subject Dosed in Phase 1b/2a Clinical Trial for Gene Therapy Candidate BB-301 for the Treatment of Oculopharyngeal Muscular Dystrophy
Yahoo Finance • last year
Benitec Biopharma to Participate in a Fireside Chat at the 35th Annual Piper Sandler Healthcare Conference
Yahoo Finance • last year
Benitec Biopharma Releases First Quarter 2024 Financial Results and Provides Operational Update
About
CEO | Dr. Jerel A. Banks M.D., Ph.D. |
CFO | Ms. Megan Joan Boston B.Com., C.A. |
Address | 3940 Trust Way, Hayward, CA, United States, 94545 |
Sector | Healthcare |
Industry | Biotechnology |
Full-Time Employees | 16 |
